EUVIMEDEUVIMED entdecken
Crossref

ABDALA, a preventive vaccine against SARS-CoV-2, is safe in Chlorocebus aethiops sabaeus monkeys

Aldana Lizet, Sosa Iliana, Polo Juan Carlos, Gutierrez Mariby, Falcón Viviana, León Avelina, Castillo Rebeca, Puente Pedro, Esteves Nancy, Valdés Rodolfo, Ayala Marta, Limonta Miladys und 2 weitere

Advances in Toxicology and Toxic Effects · 2023

DOI: 10.17352/atte.000014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Toxicology and Toxic Effects, 2023. Verfasst von Aldana Lizet und 13 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The ABDALA vaccine is a subunit vaccine developed for preventing SARS-CoV-2 infection and the progression of COVID-19 to severe forms, using as an active pharmaceutical ingredient a recombinant version of the SARS-CoV-2 spike protein receptor-binding domain (RBD) expressed in Pichia pastoris. The aim of the paper was to describe the safety profile of the ABDALA vaccine in monkeys (Cholorocebus aethiops sabaeus). For such aim, the vaccine was administered to the monkeys intramuscularly six times every 14 days, following the same scheme used in clinical trials done against COVID-19. Animals were allocated to four groups: Placebo, ABDALA Low-dose (50 µg per animal), ABDALA High-dose (100 µg per animal), and Reversion (100 µg per animal) to be submitted to a clinical, hematological and serum biochemical evaluation. Histopathological assessment of all tissues and organs was also conducted.

Results

As the main results, all animals survived and negative effects were not detected during animal clinical evaluations. The body weight and rectal temperature exhibited no variations and hematological and serum biochemical parameters showed no alterations associated with ABDALA administration. Finally, the histopathological study confirmed the proliferation of spleen white pulp due to ABDALA administration.

Conclusions

Therefore, results strongly suggest ABDALA does not cause toxic effects or damage in the organs of Chlorocebus aethiops sabaeus monkeys, indicating that it is a promising and safe novel vaccine to prevent SARS-CoV-2 infection in humans and the progression of COVID-19 to severe forms.

Zitieren

APA

Lizet, A., Iliana, S., Carlos, P. J., Mariby, G., Viviana, F., Avelina, L., Rebeca, C., Pedro, P., Nancy, E., Rodolfo, V., Marta, A., Miladys, L., Gerardo, G., & Castro, V. J. (2023). ABDALA, a preventive vaccine against SARS-CoV-2, is safe in Chlorocebus aethiops sabaeus monkeys. Advances in Toxicology and Toxic Effects. https://doi.org/10.17352/atte.000014

Vancouver

Lizet A, Iliana S, Carlos PJ, Mariby G, Viviana F, Avelina L, et al. ABDALA, a preventive vaccine against SARS-CoV-2, is safe in Chlorocebus aethiops sabaeus monkeys. Advances in Toxicology and Toxic Effects. 2023. doi:10.17352/atte.000014

BibTeX
@article{Lizet2023,
  author = {Lizet, Aldana and Iliana, Sosa and Carlos, Polo Juan and Mariby, Gutierrez and Viviana, Falcón and Avelina, León and Rebeca, Castillo and Pedro, Puente and Nancy, Esteves and Rodolfo, Valdés and Marta, Ayala and Miladys, Limonta and Gerardo, Guillén and Castro, Velazco Jorge},
  title = {ABDALA, a preventive vaccine against SARS-CoV-2, is safe in Chlorocebus aethiops sabaeus monkeys},
  journal = {Advances in Toxicology and Toxic Effects},
  year = {2023},
  doi = {10.17352/atte.000014}
}
Kostenlos starten →